Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eugene Kramolowsky

Urology Richmond, VA Medical Doctor

NPI 1558324475 CMS profile 342811

9101 Stony Point Dr, Richmond, VA 23235

Open in the dashboard

General payments

$14,654

167 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$579,720 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Eugene Kramolowsky of Richmond, VA is reported in the CMS Open Payments database as having received $14,654 across 167 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $579,720 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $58 3
2024 General $215 9
2023 General $363 16
2022 General $443 24
2021 General $1,329 48
2020 General $460 26
2019 General $11,786 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eugene Kramolowsky
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Eugene Kramolowsky were reported at $58. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Eugene Kramolowsky Urology median Middle half National median
2019 $11,786 $480 $147–$1,201 $163
2020 $460 $246 $87–$645 $114
2021 $1,329 $358 $111–$1,000 $132
2022 $443 $476 $143–$1,263 $149
2023 $363 $560 $168–$1,461 $160
2024 $215 $563 $170–$1,464 $164
2025 $58 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. PROCEPT BioRobotics Corporation $11,872 7 payments
  2. Janssen Biotech, Inc. $642 47 payments
  3. Dendreon Pharmaceuticals LLC $444 20 payments
  4. AbbVie, Inc. $265 14 payments
  5. Blue Earth Diagnostics Limited $213 10 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $182 8 payments
  7. Endo Pharmaceuticals Inc. $140 10 payments
  8. Antares Pharma, Inc. $100 5 payments
  9. Amgen Inc. $97 6 payments
  10. Rochester Medical Corporation $90 6 payments
  11. Other $609 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $10,563 3 payments
  2. Food and Beverage $2,865 162 payments
  3. Travel and Lodging $1,226 2 payments
Products named General payments · program years 2019–2025
  1. AQUABEAM ROBOTIC SYSTEM Urology $11,310 6 payments
  2. ERLEADA $627 46 payments
  3. AQUABEAM ROBOTIC SYSTEM Urology $563 1 payment
  4. PROVENGE $444 20 payments
  5. LUPRON DEPOT $222 12 payments
  6. Nubeqa $164 7 payments
  7. Axumin $145 7 payments
  8. AVEED $140 10 payments
  9. XIAFLEX $140 10 payments
  10. EDEX $140 10 payments
  11. Other $1,113 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record